SPX Daily Chart ~ This Chart Is Loaded With Technical

New Post Public Reply Private Reply Replies (0) Message Board
Big Tuna
SPX Daily Chart ~ This Chart Is Loaded With Technical Information

If your are new to charts and technical indicators, the following chart is heavy with various timing signals based solely on the technical indicators. It is the standard 9 month period which most charting services offer. As I have mentioned numerous times in the past, I look at many other, longer term indicators, but there are enough here with just the FullSto, MACDs, RSI, Bollinger Bands and the various moving averages that can help anyone substantially increase their returns based solely on technicals without fundamentals. This would be more so with the case of big board issues rather than with the OTC. If you are investing in the OTC, you'd better be damn good with the fundamentals because most are simply story stocks led by lying scum, others by inept and non qualified management teams, others nothing more than pump and dump criminals, and share selling scams. Within the OTC are are a few that truly are gems yet few and far between. This is where technicals come into play.

Below is the Daily Chart of the S&P 500. I've drawn lines and circles all over this chart, so allow me to walk you through things, one step at a time. The negative crossovers of the FullSto and MACDs are circled in pink. The positive crossovers of the same indicators are circled in yellow. All rising trend lines are in green while declining lines are red. On the chart itself I've circled the candles being outside the lower bollies in yellow circles.

Prior to the decline of the market in mid August, a few caution signs were already being seen in mid July. The RSI began to gradually weaken. The FullSto at the same time of mid July was in very overbought territory. The MACDs were just above their zero lines before flat lining coming into the end of July. I don't know what the news was in mid August to cause the selloff, but it doesn't matter as technicians were already beginning to see evidence of a weaker market or the potential of a decline. Another indication of possible trouble was the fact that the S&P wasn't able to trade and hold above the MA20 and only able to hover on it. On Aug 18 and 19, the FullSto and MACDs initiated a crossover to the downside as the market began to drip. Again, those same indicators were unable to reach higher highs since July 17. The selloff was quick and deep and on heavy volume. That heavy volume in hindsight can be caulked up as capitulation, which is indicative of most bottoms as investors panic into the selling. But if one had been following the indicators, you would more than likely not have been in the big boards or at least reduced your exposure somewhat with the weakening indicators beginning in mid July.

Finding the bottom during a decline is not that difficult, yet many investors choose to try catching a falling knife. If one were to follow the indicators while waiting for a calculated entry based on technicals, one would have been able to sidestep most of the decline. By Aug 25, the RSI, FullSto and MACDs were very oversold and deep into the basement levels. Please notice the positioning of the candles very much outside the lower bollie band.

The subsequent rally from oversold areas, ran to a point where the FullSto entered slightly overbought levels, while the MACD signal lines didn't move above their zero lines. The market reversed once again and dropped outside the lower bollies again. What one would be looking for is a leveling out or a turn back up again with the same indicators that forewarned the initial decline. More importantly, look at the higher lows put in by the RSI and the MACDs, and more importantly the higher lows of the actual S&P Index.

The Index then rallied for approx one month. Once a couple of the indicators began to reach their overbought zones, the RSI at 70 and the FullSto above 80, the Index ran into the exact same levels where it was back in mid July. A lot of profit taking and/or breakeven selling occurred. This was in early November. What is important from that point forward into the step decline of the market in early January is the gradual decline in the RSI, the FullSto and MACDs. Also note the formation of a declining tops line (red line) which obviously represents ongoing weakness. Had one paid attention to the lower highs in the RSI, FullSto, MACDs and the weaker prices on the chart, the subsequent drop in January should not have come as a surprise. The move back up in prices after a double bottom was established in mid Feb, should also have been anticipated by those who noticed the higher lows of the indicators. Although the market at this point was priced the same as in mid Jan, the same indicators discussed above were already on the rise suggesting higher prices ahead.

Charts and technicals are not guarantees but they are great tools to help one with decisions prior to possible moves in either direction. Patience and discipline are needed. Try not to catch the falling knife as it may slice you. Don't chase a stock, especially on the OTC, if all the indicators are in the overbought territories. You'll read and hear this from me over and over and over. If you follow the technicals, there will be those very few instances when a stock does something different than the normal historical patterns. Over time, you will see the results of your hard work. You might miss a trade, but there will be another train that comes by shortly. GLTA

546492150_SPX.png
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 244

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 139

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 190

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

Jeff McLean Takes the Helm as ghSMART's New CEO

Updated Category News Views 620

Jeff McLean Takes the Helm as ghSMART's New CEO G.H. Smart & Company, LLC, the leading firm in leadership advisory, proudly announces the appointment of Jeff McLean as the Chief Executive Officer. McLean, who has been serving as President of ghSMART for three years, will now guide the firm towards its next exciting phase of growth and innovation. Achievements Under...

Continue Reading
Growth Forecast for Hot Dog and Sausage Market to 2032

Updated Category News Views 51

Introduction to the Hot Dog and Sausage Market The global market for hot dogs and sausages is witnessing a remarkable upward trajectory, with projections estimating it will reach USD 112.41 billion by 2032. This growth is fueled by a compound annual growth rate (CAGR) of 3.50%. The factors contributing to this expansion are numerous, including shifting consumer...

Continue Reading
Exro Technologies Adjusts Leadership with New CEO Plans

Updated Category News Views 337

Exro Technologies Announces Leadership Changes Exro Technologies Inc. has made a significant announcement regarding its leadership structure. Following the resignation of Sue Ozdemir from her role as Chief Executive Officer, the company has initiated steps to ensure a seamless transition and continuity in leadership. New Chief Restructuring Officer Appointed Introduction...

Continue Reading
Hillenbrand Increases Quarterly Dividend to $0.225 Per Share

Updated Category News Views 208

Hillenbrand's Exciting Dividend Announcement The board of directors of Hillenbrand, Inc. (NYSE: HI) has proudly announced a regular cash dividend of $0.225 per share on its common stock. This announcement signifies an annual increase of $0.01, bringing the total dividend rate to $0.90 per share for fiscal 2025. Such a commitment underlines Hillenbrand's dedication to...

Continue Reading
Trump's World Liberty Financial Token Sale Raises $220 Million

Updated Category News Views 113

Trump's World Liberty Financial Token Sale Demonstrates Huge Demand The World Liberty Financial project, closely associated with Donald Trump, made headlines recently as its token sale reached an impressive $220 million in just the first hour. Despite facing multiple outages on its website, the initiative showcased remarkable demand and interest. Details of the Token Sale...

Continue Reading